Microfluidic fabrication of bioactive microgels for rapid formation and enhanced differentiation of stem cell spheroids

Christian Siltanen, Maliheh Yaghoobi, Amranul Haque, Jungmok You, Jeremy Lowen, Masoud Soleimani, Alexander Revzin

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

A major challenge in tissue engineering is to develop robust protocols for differentiating ES and iPS cells to functional adult tissues at a clinically relevant scale. The goal of this study is to develop a high throughput platform for generating bioactive, stem cell-laden microgels to direct differentiation in a well-defined microenvironment. We describe a droplet microfluidics system for fabricating microgels composed of polyethylene glycol and heparin, with tunable geometric, mechanical, and chemical properties, at kHz rates. Heparin-containing hydrogel particles sequestered growth factors Nodal and FGF-2, which are implicated in specifying pluripotent cells to definitive endoderm. Mouse ESCs were encapsulated into heparin microgels with a single dose of Nodal and FGF-2, and expressed high levels of endoderm markers Sox17 and FoxA2 after 5 days. These results highlight the use of microencapsulation for tailoring the stem cell microenvironment to promote directed differentiation, and may provide a straightforward path to large scale bioprocessing in the future. Statement of Significance Multicellular spheroids and microtissues are valuable for tissue engineering, but fabrication approaches typically sacrifice either precision or throughput. Microfluidic encapsulation in polymeric biomaterials is a promising technique for rapidly generating cell aggregates with excellent control of microenvironmental parameters. Here we describe the microfluidic fabrication of bioactive, heparin-based microgels, and demonstrate the adsorption of heparin-binding growth factors for enhancing directed differentiation of embryonic stem cells toward endoderm. This approach also facilitated a ∼90-fold decrease in consumption of exogenous growth factors compared to conventional differentiation protocols.

Original languageEnglish (US)
Pages (from-to)125-132
Number of pages8
JournalActa Biomaterialia
Volume34
DOIs
StatePublished - Apr 1 2016

Fingerprint

Microfluidics
Stem cells
Heparin
Stem Cells
Endoderm
Fabrication
Intercellular Signaling Peptides and Proteins
Fibroblast Growth Factor 2
Tissue Engineering
Tissue engineering
Throughput
Cellular Spheroids
Stem Cell Niche
Microencapsulation
Drug Compounding
Hydrogel
Biocompatible Materials
Embryonic Stem Cells
Encapsulation
Biomaterials

Keywords

  • Droplet microfluidics
  • Embryoid body
  • Endoderm
  • Heparin hydrogel
  • Microgel
  • Nodal

ASJC Scopus subject areas

  • Biomaterials
  • Biomedical Engineering
  • Biotechnology
  • Biochemistry
  • Molecular Biology

Cite this

Microfluidic fabrication of bioactive microgels for rapid formation and enhanced differentiation of stem cell spheroids. / Siltanen, Christian; Yaghoobi, Maliheh; Haque, Amranul; You, Jungmok; Lowen, Jeremy; Soleimani, Masoud; Revzin, Alexander.

In: Acta Biomaterialia, Vol. 34, 01.04.2016, p. 125-132.

Research output: Contribution to journalArticle

Siltanen, Christian ; Yaghoobi, Maliheh ; Haque, Amranul ; You, Jungmok ; Lowen, Jeremy ; Soleimani, Masoud ; Revzin, Alexander. / Microfluidic fabrication of bioactive microgels for rapid formation and enhanced differentiation of stem cell spheroids. In: Acta Biomaterialia. 2016 ; Vol. 34. pp. 125-132.
@article{6d987d9d08524ca88e921064ec5475a9,
title = "Microfluidic fabrication of bioactive microgels for rapid formation and enhanced differentiation of stem cell spheroids",
abstract = "A major challenge in tissue engineering is to develop robust protocols for differentiating ES and iPS cells to functional adult tissues at a clinically relevant scale. The goal of this study is to develop a high throughput platform for generating bioactive, stem cell-laden microgels to direct differentiation in a well-defined microenvironment. We describe a droplet microfluidics system for fabricating microgels composed of polyethylene glycol and heparin, with tunable geometric, mechanical, and chemical properties, at kHz rates. Heparin-containing hydrogel particles sequestered growth factors Nodal and FGF-2, which are implicated in specifying pluripotent cells to definitive endoderm. Mouse ESCs were encapsulated into heparin microgels with a single dose of Nodal and FGF-2, and expressed high levels of endoderm markers Sox17 and FoxA2 after 5 days. These results highlight the use of microencapsulation for tailoring the stem cell microenvironment to promote directed differentiation, and may provide a straightforward path to large scale bioprocessing in the future. Statement of Significance Multicellular spheroids and microtissues are valuable for tissue engineering, but fabrication approaches typically sacrifice either precision or throughput. Microfluidic encapsulation in polymeric biomaterials is a promising technique for rapidly generating cell aggregates with excellent control of microenvironmental parameters. Here we describe the microfluidic fabrication of bioactive, heparin-based microgels, and demonstrate the adsorption of heparin-binding growth factors for enhancing directed differentiation of embryonic stem cells toward endoderm. This approach also facilitated a ∼90-fold decrease in consumption of exogenous growth factors compared to conventional differentiation protocols.",
keywords = "Droplet microfluidics, Embryoid body, Endoderm, Heparin hydrogel, Microgel, Nodal",
author = "Christian Siltanen and Maliheh Yaghoobi and Amranul Haque and Jungmok You and Jeremy Lowen and Masoud Soleimani and Alexander Revzin",
year = "2016",
month = "4",
day = "1",
doi = "10.1016/j.actbio.2016.01.012",
language = "English (US)",
volume = "34",
pages = "125--132",
journal = "Acta Biomaterialia",
issn = "1742-7061",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - Microfluidic fabrication of bioactive microgels for rapid formation and enhanced differentiation of stem cell spheroids

AU - Siltanen, Christian

AU - Yaghoobi, Maliheh

AU - Haque, Amranul

AU - You, Jungmok

AU - Lowen, Jeremy

AU - Soleimani, Masoud

AU - Revzin, Alexander

PY - 2016/4/1

Y1 - 2016/4/1

N2 - A major challenge in tissue engineering is to develop robust protocols for differentiating ES and iPS cells to functional adult tissues at a clinically relevant scale. The goal of this study is to develop a high throughput platform for generating bioactive, stem cell-laden microgels to direct differentiation in a well-defined microenvironment. We describe a droplet microfluidics system for fabricating microgels composed of polyethylene glycol and heparin, with tunable geometric, mechanical, and chemical properties, at kHz rates. Heparin-containing hydrogel particles sequestered growth factors Nodal and FGF-2, which are implicated in specifying pluripotent cells to definitive endoderm. Mouse ESCs were encapsulated into heparin microgels with a single dose of Nodal and FGF-2, and expressed high levels of endoderm markers Sox17 and FoxA2 after 5 days. These results highlight the use of microencapsulation for tailoring the stem cell microenvironment to promote directed differentiation, and may provide a straightforward path to large scale bioprocessing in the future. Statement of Significance Multicellular spheroids and microtissues are valuable for tissue engineering, but fabrication approaches typically sacrifice either precision or throughput. Microfluidic encapsulation in polymeric biomaterials is a promising technique for rapidly generating cell aggregates with excellent control of microenvironmental parameters. Here we describe the microfluidic fabrication of bioactive, heparin-based microgels, and demonstrate the adsorption of heparin-binding growth factors for enhancing directed differentiation of embryonic stem cells toward endoderm. This approach also facilitated a ∼90-fold decrease in consumption of exogenous growth factors compared to conventional differentiation protocols.

AB - A major challenge in tissue engineering is to develop robust protocols for differentiating ES and iPS cells to functional adult tissues at a clinically relevant scale. The goal of this study is to develop a high throughput platform for generating bioactive, stem cell-laden microgels to direct differentiation in a well-defined microenvironment. We describe a droplet microfluidics system for fabricating microgels composed of polyethylene glycol and heparin, with tunable geometric, mechanical, and chemical properties, at kHz rates. Heparin-containing hydrogel particles sequestered growth factors Nodal and FGF-2, which are implicated in specifying pluripotent cells to definitive endoderm. Mouse ESCs were encapsulated into heparin microgels with a single dose of Nodal and FGF-2, and expressed high levels of endoderm markers Sox17 and FoxA2 after 5 days. These results highlight the use of microencapsulation for tailoring the stem cell microenvironment to promote directed differentiation, and may provide a straightforward path to large scale bioprocessing in the future. Statement of Significance Multicellular spheroids and microtissues are valuable for tissue engineering, but fabrication approaches typically sacrifice either precision or throughput. Microfluidic encapsulation in polymeric biomaterials is a promising technique for rapidly generating cell aggregates with excellent control of microenvironmental parameters. Here we describe the microfluidic fabrication of bioactive, heparin-based microgels, and demonstrate the adsorption of heparin-binding growth factors for enhancing directed differentiation of embryonic stem cells toward endoderm. This approach also facilitated a ∼90-fold decrease in consumption of exogenous growth factors compared to conventional differentiation protocols.

KW - Droplet microfluidics

KW - Embryoid body

KW - Endoderm

KW - Heparin hydrogel

KW - Microgel

KW - Nodal

UR - http://www.scopus.com/inward/record.url?scp=84955239755&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84955239755&partnerID=8YFLogxK

U2 - 10.1016/j.actbio.2016.01.012

DO - 10.1016/j.actbio.2016.01.012

M3 - Article

C2 - 26774761

AN - SCOPUS:84955239755

VL - 34

SP - 125

EP - 132

JO - Acta Biomaterialia

JF - Acta Biomaterialia

SN - 1742-7061

ER -